|
![]() |
|
|
Metaxalone
drug data and news
Metaxalone drug data, resources, and news articles (when available). Onconews.org provides news on cancer research. This section, which includes profiles on medicines that may or not be cancer-related is in beta form. If things run smoothly we will be releasing a new format late in the summer of 2006.
|
| Generic name | Metaxalone | ||
| Brand Names/Synonyms | .Meta.Xalon; .Meta.Xalone; .Meta.Zalone; .Meta.Zolone; AHR 438; AHR-438; HSDB 3236; Metassalone [Dcit]; Metaxalon; Metaxalona [Inn-Spanish]; Metaxalona [Spanish]; Metaxalone; Metaxalone [Usan:Ban:Inn]; Metaxalonum [Inn-Latin]; Metaxalonum [Latin]; Metazalone; Metazolone; Methaxalonum; Methoxolone; Skelaxin; Zorane | ||
| Indication | For the treatment of painful musculoskeletal conditions | ||
| Sponsored links | Description | Not Available | |
| Pharmacology | Metaxalone is a skeletal muscle relaxant indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomforts associated with acute, painful musculoskeletal conditions. The mode of action of this drug has not been clearly identified, but may be related to its sedative properties. Metaxalone does not directly relax tense skeletal muscles in man. | ||
| Mechanism Of Action | The mechanism of action of metaxalone in humans has not been established, but may be due to general central nervous system depression. | ||
| Metaxalone News (When available) |
King Pharmaceuticals Reports Year-End and Fourth-Quarter 2005 ... Feb 28, 2006 Pain Therapeutics and King Pharmaceuticals Receive Special ... Feb 16, 2006 Murder defendant indicted on new charge Jan 11, 2006 King Pharmaceuticals Announces Cross-License Agreement with Mutual ... Dec 10, 2005 King Pharmaceuticals Reports Third-Quarter 2005 Financial Results Nov 9, 2005 King Pharmaceuticals Reports Third-Quarter 2005 Financial Results Nov 9, 2005 King Pharmaceuticals Reports Second-Quarter 2005 Financial Results Sep 9, 2005 King Pharmaceuticals Appoints Joseph Squicciarino Chief Financial ... Jun 1, 2005 King Pharmaceuticals Reports First-Quarter 2005 Financial Results May 9, 2005 King Pharmaceuticals Completes Wholesale Inventory Reductions May 3, 2005 King Pharmaceuticals Repositioned for Growth Feb 28, 2005 | ||
| Dosage Forms | Tablet | ||
| Drug_Category | Muscle Relaxants, skeletal muscle; Analgesics; Hypnotics and Sedatives; | ||
| Absorption | Not Available | ||
| Interactions |
Interactions for Metaxalone: SKELAXIN may enhance the effects of alcohol, barbiturates and other CNS depressants. | ||
| Toxicity | LD50=775mg/kg (Rat, oral); LD50=1690 mg/kg (Mouse, oral) | ||
| Organisms Affected | Humans and other mammals | ||
| Chemical IUPAC Name | 5-[(3,5-dimethylphenoxy)methyl]oxazolidin-2-one | ||
| Chemical Formula | C12H15NO3 | ||
| Molecular Weight | 221.252 g/mol | ||
| Smiles String | CC1=CC(=CC(=C1)OCC2CNC(=O)O2)C | ||
| Melting Point | 122 °C | ||
| Water Solubility | Not Available | ||
| State | Solid | ||
| LogP/Hphobicity | 1.603 | ||
| Isoelectric Point | Not Available | ||
| Biotransformation | Probably hepatic | ||
| Half Life | 9.2 (+/- 4.8) hours | ||
| Protein Binding [%] | Not Available | ||
| RxList Link | RXlist | ||
| Sponsored links | |||
| Drug Reference |
http://www.drugs.com/cons/Metaxalone.html http://www.rxlist.com/cgi/generic/metax.htm | ||
| Drug Type | Approved Drug | ||
| Accession No | APRD00514 | ||
| CAS Registry Number | 1665-48-1 | ||
| KEGG Compound ID | C07934 | ||
| PubChem ID | SID:158778 | ||
| PharmGKB ID | PA450394 | ||
| SwissProt ID | Not Available | ||
| GenBank ID | Not Available | ||
| Drug ID Number [DIN] | Not Available |
|
Home | About | Cancers | Treatment | Medications Copyright onconews.org 2005. All Rights Reserved. |